论文部分内容阅读
采用放射介入治疗中晚期肺癌及并发症 42例 ,其中中央型肺癌 2 4例 ( 5 7.1%) ;周围型肺癌 16例 ( 3 8.1%) ;肺内多个转移灶 2例 ( 4 .8%)。采用支气管动脉灌注 ( BAI) 40例 ,支气管动脉灌注及栓塞 ( BAIE) 1例 ,髂外静脉及肘静脉溶栓 1例。 1次介入治疗 3 2例 ,多次介入治疗 10例 ,间隔时间为 2 8～ 3 0天 ,灌注用联合化疗方案 ,无并发症发生。BAI后肿块影缩小 5 0 %以上 3 6例 ( 85 .7%) ;转移性癌均无明显缩小 ;BAIE后咯血停止 ,溶栓后血管通畅 ,局部肿胀消退 ,BAI具有创伤小 ,并发症少 ,可重复进行的优点。灌注药物宜用联合化疗方案 ,介入治疗的疗效与肿瘤的血供来源及介入径路有关 ,肺癌并发症的介入治疗尚需注意时机和相关的治疗。
There were 42 patients with advanced lung cancer and complications treated with radiation intervention, including 24 patients with central lung cancer (5 7.1%), 16 patients with peripheral lung cancer (3.1%), and 2 patients with multiple metastases in the lung ( 4.8% ). Bronchial arterial infusion (BAI) was performed in 40 cases, bronchial arterial infusion and embolization (BAIE) in 1 case, and external iliac vein and ulnar vein thrombolysis in 1 case. One interventional treatment was performed in 32 patients and multiple interventional treatments were performed in 10 patients. The interval time was 28 to 30 days. Infusion combined with chemotherapy was used without complications. After BAI, the tumor size decreased by more than 50% in 3-6 patients (85.7%); metastatic cancer was not significantly reduced; hemoptysis was stopped after BAIE, blood vessels were patency after thrombolysis, local swelling subsided, and BAI had less trauma and fewer complications. , repeatable advantages. Intravenous drugs should be treated with a combination chemotherapy regimen. The efficacy of interventional therapy is related to the source of blood supply and the intervention pathway of the tumor. Interventional treatment of lung cancer complications requires attention to the timing and related treatment.